ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668263 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668263; 2) Community: the network communities that were significantly associated with the response to NSC 668263; 3) Molecule: the relationships between components within communities and NSC 668263; 4) MDR: the compounds that were significantly associated with the NSC 668263.

NSC Compound Enrichment Correlation
NSC 695945 Null 0.0382675857669587 0.28656262
NSC 683557 Camptothecin Derivative 0.0382675857669588 0.17869057
NSC 714362 Null 0.0382675857669588 0.025295201
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.0382675857669588 0.011533463
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0382675857669588 0.10731733
NSC 732112 6-(O-ethyl-2?-diethylamino)-7-(p-methoxycinnamoyl)-3-methyl- benzofuran-2-carboxylic acid ethyl ester hydrochloride 0.0382675857669588 0.072113611
NSC 10037 Null 0.0414190425892865 0.47043824
NSC 176098 Phosphonium, methyl[2-methyl-2-(4-methylphenyl)propyl]diphenyl-, iodide 0.0414190425892865 0.45768288
NSC 255104 Des-O-methylgeldanamycin 0.0414190425892865 0.49127303
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0414190425892865 -0.0040452681
Total:56  Current:46    [First] [Prev] [Next] [Last]